THE NURSES ROLE IN PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) WITH LUTATHERA

被引：0
|
作者：
Longing, Anne [1 ]
Boswell, Abigail [1 ]
Kennedy, Matthew [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
29
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Peptide receptor radionuclide therapy (PRRT) of midgut neuroendocrine tumors: assessment of quality of life
    Marinova, Milka
    Muecke, Martin
    Fischer, Felix
    Essler, Markus
    Cuhls, Henning
    Radbruch, Lukas
    Ahmadzadehfar, Hojjat
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [33] CHANGES IN GLOMERULAR FILTRATION RATE (GFR) FOLLOWING PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT)
    Edison, R.
    Cluff, A.
    Hayes, E.
    Schembri, G. P.
    Bailey, E. A.
    [J]. INTERNAL MEDICINE JOURNAL, 2017, 47 : 36 - 36
  • [34] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    [J]. BLOOD, 2020, 136
  • [35] Prognosis of patients with carcinoid heart disease treated by peptide receptor radionuclide therapy (PRRT)
    Prasad, V.
    Secknus, M. A.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [36] A combination of external beam radiotherapy with peptide receptor radionuclide therapy (PRRT) in irresectable meningeoma
    Kreissl, M.
    Haenscheid, H.
    Polat, B.
    Verburg, F. A.
    Kaiser, F. R.
    Reiners, C.
    Samnick, S.
    Flentje, M.
    Buck, A. K.
    Sweeney, R.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (09) : 595 - 595
  • [37] Chronic Complications of Peptide Receptor Radionuclide Therapy (PRRT) - A Single Center Experience.
    Fraenkel, M.
    Barak, D.
    Mueller-Brand, J.
    Krausz, Y.
    Glaser, B.
    Salmon, A.
    Gross, D. J.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [38] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [39] A single institution experience with peptide receptor radionuclide therapy (PRRT) in advanced pheochromocytoma and paraganglioma
    Duan, H.
    Ferri, V
    Fisher, G.
    Shaheen, S.
    Davidzon, G.
    Moradi, F.
    Nguyen, J.
    Franc, B.
    Iagaru, A.
    Mari, Aparici C.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 180 - 180
  • [40] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; dosimetric findings
    Mok, S.
    Tay, Y.
    Ng, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
12345